Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enzymatically Augmented Subcutaneous Infusion (EASI) Access II Trial

NCT00740727 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00740727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00740727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enzymatically Augmented Subcutaneous Infusion (EASI) Access II Trial
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2009
Completion date
March 31, 2009
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dehydration, difficult intravenous access, disaster medicine